Elevance Health 2024 Profits Hit $6 Billion Despite Rising Costs
Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer worked to overcome rising medical expenses.
Elevance Health expects to grow MA membership by at least 7% in 2025
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's expectations despite decreasing 51% year-over-year. | Elevance Health posted $418 million in profit for the fourth quarter of 2024,
Elevance Health expects high Medicaid costs to drop in 2025
Medicaid managed care organizations, including Elevance Health, Centene and UnitedHealth Group, are working with states to secure rates that account for sicker patients.
Elevance beats profit estimates on lower-than-expected medical costs
(Reuters) -Elevance Health on Thursday posted quarterly profit slightly above Wall Street expectations, helped by lower-than-expected spending on medical care for its members. The results lifted Elevance's shares more than 5% before the bell and also boosted peers such as Cigna and CVS Health.
Elevance sends Medicaid insurers higher after Q4 revenue beat
Centene (CNC) and Molina Healthcare (MOH) were among the notable gainers in the premarket on Thursday after their rival in the Medicaid space, Elevance Health (NYSE:ELV), reported better-than-expected revenue for Q4 2024.
Elevance Health (ELV) Q4 2024 Earnings Call Transcript
Operator instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to ...
Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend
Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, ...
Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...
Elevance Health (ELV) Initiated with a Buy at Cantor Fitzgerald
Elevance Health (ELV – Research Report) received a Buy rating and a $485.00 price target from Cantor Fitzgerald analyst Sarah James yesterday.
Ibj.com3d
UPDATE: Elevance Health shares tick up on better-than-expected earnings
Elevance Health released fourth-quarter earnings that topped analyst expectations, sending its stock higher in pre-market ...
Managed Care Insurers Get Wall Street Bump Even With Mixed Q4 2024 Results
After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...
Elevance Health (ELV) Receives a Buy from Truist Financial
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Elevance Health (ELV – Research Report), with a ...
Elevance Health's Options: A Look at What the Big Money is Thinking
Delving into the details, we found 50% of traders were bullish, while 41% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $248,785, and 4 were calls, valued ...
Elevance Health Inc. (NYSE:ELV) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, ...